Cambridge Nutritional SciencesFRA:RVKA Gross Margin % is 67.69% as of Sep. 2025, which is 6% above its 10-year median of 63.97. The stock has 3 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Cambridge Nutritional Sciences ranks better than 74.04% on this metric.
FRA:RVKA's Gross Margin % is ranked better than 74.04% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 51.94
vs FRA:RVKA: 66.44
Cambridge Nutritional Sciences had a gross margin of 67.69% for the quarter that ended in Sep. 2025 => Durable competitive advantage
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Cambridge Nutritional Sciences had a gross margin of 67.69% for the quarter that ended in Sep. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Cambridge Nutritional Sciences Gross Margin % Related Terms
Cambridge Nutritional Sciences Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:RVKA vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cambridge Nutritional Sciences Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Cambridge Nutritional Sciences's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Cambridge Nutritional Sciences (FRA:RVKA) has a Gross Margin % of 67.69% as of Sep. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Cambridge Nutritional Sciences and its competitors. This is near median its historical median of 63.97. Over the past decade, Cambridge Nutritional Sciences' Gross Margin % has ranged from 46.98 to 66.44. According to the industry distribution chart, Cambridge Nutritional Sciences ranks #209 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 26%.
Is Cambridge Nutritional Sciences' Gross Margin % too high?
Cambridge Nutritional Sciences' current Gross Margin % of 67.69% is near median its 10-year median of 63.97. Over the past 10 years, this metric has ranged from a low of 46.98 to a high of 66.44. The Medical Devices & Instruments industry median Gross Margin % is 51.94. Cambridge Nutritional Sciences' value of 67.69% is 30.3% above this industry median. Based on the distribution chart, Cambridge Nutritional Sciences ranks #209 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Cambridge Nutritional Sciences' Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Cambridge Nutritional Sciences ranks #209 out of 805 companies for Gross Margin %. This puts Cambridge Nutritional Sciences in the upper half of its industry. The industry median Gross Margin % is 51.94. Cambridge Nutritional Sciences' value of 67.69% is 30.3% above this benchmark. Historically, Cambridge Nutritional Sciences' own Gross Margin % has ranged from 46.98 to 66.44 over the past decade. While the company's 10-year median is 63.97 vs. the industry median of 51.94, Cambridge Nutritional Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cambridge Nutritional Sciences's current Gross Margin % of 67.69% is 30.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Cambridge Nutritional Sciences and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cambridge Nutritional Sciences's current Gross Margin % is 67.69%, which is near median its own 10-year median of 63.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Nutritional Sciences stock overvalued right now?
Cambridge Nutritional Sciences (FRA:RVKA) has a current Gross Margin % of 67.69%. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 32.5% below its estimated fair value. The current Gross Margin % is 67.69%, which is near median its 10-year median of 63.97 and 30.3% above the Medical Devices & Instruments industry median of 51.94. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Cambridge Nutritional Sciences (FRA:RVKA), the current Gross Margin % is 67.69% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cambridge Nutritional Sciences Business Description
Cambridge Nutritional Sciences PLC is a medical diagnostics company specializing in the development, manufacture, and distribution of food sensitivity test kits. Its product portfolio includes tests designed to detect immune reactions to various foods, helping healthcare professionals and patients identify dietary and lifestyle changes to improve long-term health and wellbeing. The company operates in the United Kingdom and serves the customer base across various countries through laboratories and healthcare providers. It generates revenue by selling diagnostic kits and providing clinical analysis services centered on food sensitivity and gut health. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition segment generates majority revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:RVKA has been successfully added to your 